Affordable access to essential medication in developing countries: Conflicts between ethical and economic imperatives

Journal of Medicine and Philosophy

Volumn 27, Issue 2, 2002, Pages 179-195

  Schüklenk, Udo ^a   Ashcroft, Richard E ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

African; Bioethics; Drug pricing; Ethics; HIV AIDS; Intellectual property; Licensing; Patent; Pharmaceuticals; Population health; Poverty; Resource allocation

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ARTICLE; DEATH; DEVELOPING COUNTRY; DRUG COST; DRUG INDUSTRY; ECONOMICS; ETHICS; HEALTH CARE ACCESS; HUMAN IMMUNODEFICIENCY VIRUS; LICENSING; MORBIDITY; POLITICS; POPULATION; POVERTY; PUBLIC HEALTH; RESOURCE ALLOCATION; SOUTHEAST ASIA;

HEALTH CARE AND PUBLIC HEALTH;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA SOUTH OF THE SAHARA; ANTI-HIV AGENTS; ASIA, SOUTHEASTERN; CONFLICT (PSYCHOLOGY); COOPERATIVE BEHAVIOR; DEVELOPING COUNTRIES; DRUG APPROVAL; DRUG COSTS; DRUG INDUSTRY; ETHICS; HEALTH CARE RATIONING; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; PATENTS; POVERTY; PRIVATE SECTOR; PUBLIC HEALTH ADMINISTRATION; PUBLIC SECTOR;

EID: 0036264278     PISSN: 03605310     EISSN: None     Source Type: Journal    
DOI: 10.1076/jmep.27.2.179.2989     Document Type: Article

References (31)

1. Declarations and covenants on human rights and international codes of research ethics
2. Why don't we enforce existing price controls? The unrecognized and unenforced reasonable pricing requirements imposed upon patents deriving in whole or in part from federally-funded research
3. Bitter pill
4. Some questions about the moral responsibilities of drug companies
5. UN Agency calls on drug firms to do more in AIDS fight
6. Social responsibility and global pharmaceutical companies
7. The private finance initiative: The politics of the private finance initiative and the new NHS
8. Drug firms reap profits on tax-backed research
9. Ewriting the regulations: How the World Trade Organization could accelerate privatization in health systems
10. How the World Trade Organisation is shaping domestic policies in health care
11. Developing drugs for the developing world: An economic, legal, moral and political dilemma
12. Glaxo attempts to block access to generic AIDS drugs in Ghana
13. Toronto research funding dispute